Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2022

Identification of circRNAs involved in the development of hepatocellular carcinoma after insufficient radiofrequency ablation
Authors: Jun-Wei Chen, Li-Sha Lai, Jun-Yang Luo, Chu-Ren Zhou, Min-Gan Li, Ming-Sheng Huang, Ping Wu
Neoplasma Vol.69, No.3, p.527–537, 2022
doi:10.4149/neo_2021_210817N1170
[View Abstract]


Exosomal circRNAs as novel potential biomarkers for colorectal adenoma
Authors: Shaobing Cheng, Sen Lu, Fanlong Liu
Neoplasma Vol.69, No.3, p.516–526, 2022
doi:10.4149/neo_2021_210718N986
[View Abstract]


Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential
Authors: Ji-Zheng Tian, Ni-Na Ma, Xiao Li, Kun Shang, Bang-Wei Cao
Neoplasma Vol.69, No.3, p.504–515, 2022
doi:10.4149/neo_2021_211006N1412
[View Abstract]


Periostin: a predictable molecule to prognosis and chemotherapy responses of gastrointestinal and hepato-biliary-pancreatic malignant tumors?
Authors: Wei Zhang, Fa-Hong Wu, Jia Wang, Hang-Zhi Wei, Tian-Wei Wang, You-Cheng Zhang
Neoplasma Vol.69, No.3, p.491–503, 2022
doi:10.4149/neo_2021_211025N1521
[View Abstract]


Clinicopathological characteristics and prognosis of breast cancer patients with lung cancer: A study based on 19,807 breast cancer patients
Authors: Jin-Zhao Liu, Wei-Fang Zhang, Xiao-Fei Ren, Geng Zhang, Chao Yang, Shuo Zhang, Xiang-Mei Zhang, Yun-Jiang Liu
Neoplasma Vol.69, No.2, p.484–490, 2022
doi:10.4149/neo_2022_210821N1197
[View Abstract]


Novel biochemical markers for non-invasive detection of pancreatic cancer
Authors: Pavel Hrabák, Jan Šoupal, Marta Kalousová, Tomáš Krechler, Michal Vočka, Tomáš Hanuš, Luboš Petruželka, Štěpán Svačina, Aleš Žák, Tomáš Zima
Neoplasma Vol.69, No.2, p.474–483, 2022
doi:10.4149/neo_2022_210730N1075
[View Abstract]


Exploring the prognosis of neuroblastoma in adolescents and adults: a case series and literature review
Authors: Qian-Ya Jin, Shi-Bei Du, Xiao-Jun Yuan
Neoplasma Vol.69, No.2, p.464–473, 2022
doi:10.4149/neo_2021_210325N399
[View Abstract]


Low-molecular-weight heparin prophylaxis is not associated with decreased incidence of venous thromboembolism in testicular germ cell tumor patients receiving chemotherapy
Authors: Nikola Hapakova, Michal Chovanec, Katarina Rejlekova, Katarina Kalavska, Jana Obertova, Patrik Palacka, Valentina De Angelis, Zuzana Sycova-Mila, Jozef Mardiak, Michal Mego
Neoplasma Vol.69, No.2, p.456–463, 2022
doi:10.4149/neo_2021_210909N1295
[View Abstract]


Genetic contributions of MHC class I antigen processing and presentation pathway to bladder cancer risk and recurrence
Authors: Edyta Wieczorek, Zbigniew Jablonowski, Monika Lesicka, Ewa Jablonska, Piotr Kutwin, Edyta Reszka, Malgorzata Anna Garstka
Neoplasma Vol.69, No.2, p.443–455, 2022
doi:10.4149/neo_2021_210805N1113
[View Abstract]


Prognostic potential of circulating miR-93-5p in patients with colorectal cancer liver metastases
Authors: Jovana Despotović, Aleksandar Bogdanović, Sandra Dragičević, Danijel Galun, Zoran Krivokapić, Aleksandra Nikolić
Neoplasma Vol.69, No.2, p.430–442, 2022
doi:10.4149/neo_2021_210603N749
[View Abstract]


Axillary reverse mapping in breast cancer surgery – functional study
Authors: David Pavlista, Lukas Dostalek, Zuzana Velenska
Neoplasma Vol.69, No.2, p.425–429, 2022
doi:10.4149/neo_2021_210622N830
[View Abstract]


Proteomic analysis of the bone marrow microenvironment in extramedullary multiple myeloma patients
Authors: Jana Gregorova, Petra Vychytilova-Faltejskova, Tereza Kramarova, Zdenka Knechtova, Martina Almasi, Martin Stork, Ludek Pour, Jiri Kohoutek, Sabina Sevcikova
Neoplasma Vol.69, No.2, p.412–424, 2022
doi:10.4149/neo_2021_210527N715
[View Abstract]


Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis
Authors: Giulia Corrao, Giulia Marvaso, Mattia Zaffaroni, Stefania Volpe, Matteo Augugliaro, Cristiana Iuliana Fodor, Dario Zerini, Andrea Vingiani, Francesco Alessandro Mistretta, Stefano Luzzago, Sarah Alessi, Paola Pricolo, Gennaro Musi, Ottavio De Cobelli, Giuseppe Renne, Marco Manzoni, Giuseppe Petralia, Roberto Orecchia, Barbara Alicja Jereczek-Fossa
Neoplasma Vol.69, No.2, p.404–411, 2022
doi:10.4149/neo_2021_210622N828
[View Abstract]


Circ_0020123 regulates autophagy, glycolysis, and malignancy by upregulating IRF4 through eliminating miR-193a-3p-mediated suppression of IRF4 in non-small cell lung cancer
Authors: Xing-Ping Yang, Yu-Zhen Zheng, Jian Tan, Ren-Jiang Tian, Piao Shen, Wei-Jie Cai, Hong-Ying Liao
Neoplasma Vol.69, No.2, p.392–403, 2022
doi:10.4149/neo_2022_211013N1449
[View Abstract]


The Hu antigen R/interferon-β axis modulates sensitivity of esophageal squamous cancer cells to cisplatin
Authors: Ya-Yun Cui, Xiao-Feng Zhu, Shu Zhang
Neoplasma Vol.69, No.2, p.383–391, 2022
doi:10.4149/neo_2022_210910N1299
[View Abstract]


TRIM35 functions as a novel tumor suppressor in breast cancer by inducing cell apoptosis through ubiquitination of PDK1
Authors: Rong Wang, Ke-Liang Huang, Lian-Xiang Xing
Neoplasma Vol.69, No.2, p.370–382, 2022
doi:10.4149/neo_2021_210823N1205
[View Abstract]


ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway
Authors: Wei Wang, Lina Xiao, Deng Pan, Lingzhi Hu
Neoplasma Vol.69, No.2, p.361–369, 2022
doi:10.4149/neo_2021_210818N1181
[View Abstract]


Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing
Authors: Hui Zhang, Da Jiang, Hui Jin, Yan-Zhi Cui, Su-Ju Wei, Ying Li, Qian Dong, Jing Zuo, Cai-Juan Tian, Fang Yan, Xiao-Wei Wang
Neoplasma Vol.69, No.2, p.352–360, 2022
doi:10.4149/neo_2021_210914N1307
[View Abstract]


Hyper-expression and hypomethylation of TM4SF1 are associated with lymph node metastases in papillary thyroid carcinoma patients
Authors: Kun Wang, Juan Zheng, Zhen Wu, Ju-Gao Fang, Jun-Yu Zhao, Jin-Ming Yao, Jian-Jun Dong, Jie Bai, Lin Liao
Neoplasma Vol.69, No.2, p.341–351, 2022
doi:10.4149/neo_2021_210819N1191
[View Abstract]


Liver X receptors agonist T0901317 exerts ferroptosis sensitization in cancer
Authors: Meng-Ting Zhou, Zhen-Yu Li, Jun Fan, Pin-Dong Li, Ye Wang, Sheng Zhang, Xiao-Fang Dai
Neoplasma Vol.69, No.2, p.331–340, 2022
doi:10.4149/neo_2021_210810N1132
[View Abstract]





Display #  
Results 21 - 40 of 72

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.